These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 35737644)
1. Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection. Tang Y; Luo J; Yang Y; Liu S; Zheng H; Zhan Y; Fan S; Wen Q PLoS One; 2022; 17(6):e0265465. PubMed ID: 35737644 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer. Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262 [TBL] [Abstract][Full Text] [Related]
3. eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy. Huang CI; Wang CC; Tai TS; Hwang TZ; Yang CC; Hsu CM; Su YC PLoS One; 2019; 14(11):e0225537. PubMed ID: 31756179 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. Yoshizawa A; Fukuoka J; Shimizu S; Shilo K; Franks TJ; Hewitt SM; Fujii T; Cordon-Cardo C; Jen J; Travis WD Clin Cancer Res; 2010 Jan; 16(1):240-8. PubMed ID: 20008839 [TBL] [Abstract][Full Text] [Related]
5. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer. Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433 [TBL] [Abstract][Full Text] [Related]
6. [Over-expressions of p-eIF4E and p-4EBP1 are associated with poor prognosis in nasopharyngeal carcinoma]. Zheng J; Zhang C; Zhang Y; Pei J; Fan S Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Apr; 33(4):531-535. PubMed ID: 28395726 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma. Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348 [TBL] [Abstract][Full Text] [Related]
8. Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer. Tang Y; Luo J; Zhou Y; Zang H; Yang Y; Liu S; Zheng H; Ma J; Fan S; Wen Q BMC Cancer; 2022 May; 22(1):564. PubMed ID: 35596155 [TBL] [Abstract][Full Text] [Related]
9. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice. Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer. Lee HW; Lee EH; Lee JH; Kim JE; Kim SH; Kim TG; Hwang SW; Kang KW Int J Clin Exp Pathol; 2015; 8(4):3955-62. PubMed ID: 26097581 [TBL] [Abstract][Full Text] [Related]
11. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer. Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142 [TBL] [Abstract][Full Text] [Related]
12. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway. Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281 [TBL] [Abstract][Full Text] [Related]
13. RIP3/MLKL regulates necroptosis via activating 4EBP1-eIF4E pathway. Wang S; Xu M Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):979-985. PubMed ID: 37724400 [TBL] [Abstract][Full Text] [Related]
14. Levels of 4EBP1/eIF4E Activation in Renal Cell Carcinoma Could Differentially Predict Its Early and Late Recurrence. Ichiyanagi O; Naito S; Ito H; Kabasawa T; Narisawa T; Kanno H; Kurota Y; Kurokawa M; Fukuhara H; Sakurai T; Nishida H; Kato T; Yamakawa M; Tsuchiya N Clin Genitourin Cancer; 2018 Oct; 16(5):e1029-e1058. PubMed ID: 30297141 [TBL] [Abstract][Full Text] [Related]
15. Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer. Liu S; Wang W; Ning Y; Zheng H; Zhan Y; Wang H; Yang Y; Luo J; Wen Q; Zang H; Peng J; Ma J; Fan S Cell Death Dis; 2022 Feb; 13(2):129. PubMed ID: 35136028 [TBL] [Abstract][Full Text] [Related]
16. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer. Khoury T; Alrawi S; Ramnath N; Li Q; Grimm M; Black J; Tan D Clin Lung Cancer; 2009 Jan; 10(1):58-66. PubMed ID: 19289374 [TBL] [Abstract][Full Text] [Related]
17. [Expression and its clinical significance of eIF4E in non-small cell lung cancer]. ZHANG B; ZHU C; CHEN B; ZHANG X; YE M; LIN A Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1132-5. PubMed ID: 21159249 [TBL] [Abstract][Full Text] [Related]
18. Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer. Pang W; Tian X; Bai F; Han R; Wang J; Shen H; Zhang X; Liu Y; Yan X; Jiang F; Xing L Mol Cancer; 2014 Oct; 13():240. PubMed ID: 25342548 [TBL] [Abstract][Full Text] [Related]
19. Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer. Li Y; Fan S; Koo J; Yue P; Chen ZG; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY Cancer Biol Ther; 2012 Mar; 13(5):272-80. PubMed ID: 22236867 [TBL] [Abstract][Full Text] [Related]
20. [Expression of hUTP14a in non-small cell lung cancer]. Zhang CF; Liu Y; Lu M; DU XJ Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):145-150. PubMed ID: 30773559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]